2019 Biotech Startups
Order by: Company Name - Location
 Agilex Biolabs |
Australia - Thebarton | Bioanalytical Clinical Testing |
| AgomAb Therapeutics |
Belgium - Sint-Denijs-Westrem | Agonistic monoclonal antibody molecules |
| Alentis Therapeutics |
Switzerland - Basel | Monoclonal Antibody |
| Arvelle Therapeutics |
Switzerland - Basel | Small Molecules |
| Aurealis Therapeutics |
Switzerland - Basel | Transdermal |
| Avance Clinical |
Australia - Thebarton | Clinical Research |
| BYOMass |
MA - SUDBURY | Metabolic Therapies |
| Corza Health |
CA - San Diego | Looking to Acquire companies |
| Cyclerion Therapeutics |
MA - Cambridge | Small Molecules |
| Dermelix Biotherapeutics |
NY - New York | Rare Genetic Skin Disease Treatments |
| Geneos Therapeutics |
PA - Plymouth Meeting | Plasmid-based Neoantigen-targeted Cancer Therapies |
| HiberCell |
NY - New York | Tumor dormancy detection and treatments |
| Imbrium Therapeutics |
CT - Stamford | Small Molecules |
| Maze Therapeutics |
CA - Redwood City | Genetic Modifiers of Disease |
| Nimble Therapeutics |
WI - Madison | Photoprotected Amino Acids |
| PolyProx Therapeutics |
UK - Cambridge | Engineered Proteins |
| Secura Bio |
NV - Henderson | Acquisition & Worldwide Commercialization |
| SNIPR Biome |
Denmark - Copenhagen | CRISPR for microbiome management |
| Verve Therapeutics |
MA - Cambridge | Gene-editing Treatments |
| Verve Therapeutics |
PA - Philadelphia | Gene-editing Treatments |
| Wings Therapeutics |
CA - Berkeley | RNA therapy for dystrophic epidermolysis bullosa treatment |